| |
| |
|
| Insider
Information: |
Sabella Lauren M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
386,061 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,694,456 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
386,061 |
|
|
| Total
Value |
$1,694,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Operating Officer |
2022-09-03 |
10,710 |
|
0 |
Premium* |
|
|
MannKind Corp |
MNKD |
|
2024-05-15 |
375,351 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-12-01 |
4 |
AS |
$38.06 |
$270,481 |
D/D |
(7,106) |
14,378 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-12-22 |
4 |
AS |
$42.04 |
$299,063 |
D/D |
(7,113) |
14,378 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-12-22 |
4 |
OE |
$22.06 |
$156,913 |
D/D |
7,113 |
21,491 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-05-18 |
4 |
AS |
$23.67 |
$172,471 |
D/D |
(7,288) |
11,165 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2013-12-05 |
4 |
AS |
$31.81 |
$279,830 |
D/D |
(8,797) |
12,403 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,045 |
14,137 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,313 |
31,380 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2013-11-22 |
4 |
AS |
$33.72 |
$369,206 |
D/D |
(10,949) |
27,803 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,125 |
13,732 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2023-05-15 |
4 |
A |
$4.23 |
$59,998 |
D/D |
14,184 |
14,184 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2024-02-04 |
4 |
A |
$3.27 |
$49,998 |
D/D |
15,290 |
263,435 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2024-03-27 |
4 |
D |
$4.63 |
$79,099 |
D/D |
(17,084) |
246,351 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
23,250 |
247,434 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-06-08 |
4 |
AS |
$35.00 |
$853,125 |
D/D |
(24,375) |
11,165 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-06-08 |
4 |
OE |
$16.50 |
$402,188 |
D/D |
24,375 |
35,540 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
129,000 |
375,351 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
210,000 |
224,184 |
0 |
- |
|
42 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
